Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Part of paid clinical trials in Buffalo, New York.

Sponsor
State University of New York at Buffalo
Study ID
NCT06172283
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Intermittent Fasting — OTHER
    Dietary intervention

Study Details

This is a a pilot study to assess the feasibility of intermittent caloric restriction (plus a plant-enriched diet optionally) in prostate cancer patients receiving androgen deprivation therapy. Study feasibility measures will include enrollment rate, drop-out rate and compliance with diet measured by self-reports.

Key Dates

Start date
Dec 5, 2023
Status verified
Apr 2026
Primary completion
Jan 1, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Intermittent Fasting
    Patients will undergo 16h periods of fasting everyday. Optionally, patients will be offered to undergo a plant-based diet consisting of 20% plant based protein, 50% carbohydrates, and 30% fat for the duration of the study.

Primary Outcome Measure

Enrollment rate [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University at Buffalo/Great Lakes Cancer CenterBuffaloNew York14203
Roberto Pili
[email protected]
716-881-8918

Find similar trials in Buffalo, NY

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
University at Buffalo/Great Lakes Cancer Center· Buffalo, NY

Related Studies